Butterworth, J.F. (1993) “Bupivacaine Inhibits Cyclic-3′, 5′-Adenosine Monophosphate Production” Anesthesiology 79:88-95. |
Mazoit, J.X. et al. (1983) “Myocardial Uptake of Bupivacaine: II. Pharmacokinetics and Pharmacodynamics of Bupivacaine Enantiomers in the Isolated Perfused Rabbit Heart” Anesth. Anal. 77(3):477-482. |
Clarkson, C.W., L.M. Hondeghem (1985) “ Mechanism for Bupivacaine Depression of Cardiac Conduction: Fast Block of Sodium Channels during the Action Potential with Slow Recovery from Block during Diastole” Anesthesiology 62:396-405. |
Courtney, K.R., J.J. Kendig (1988) “Bupivacaine is an effective potassium channel blocker in heart” Biochimica et Biophysica Acta 939:163-166. |
Denson, D.D., M.M Behbehani, R.V. Gregg (1992) “Enantiomer-Specific Effects of an Intravenously Administered Arrhythymogenic Dose of Bupivacaine on Neurons of the Nucleus Tractus of Solitarius and the Cardiovascular System in the Anesthetized Rat” Regional Anesthesia 17(6):311-316. |
Vanhoutte, F. et al. (1991) “Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea-pig papillary muscle” Br. J. Pharmacol. 103:1275-1281. |
Valenzuela, C. et al. (1994) “Stereoselective Bupivacaine Block of the Human Cardiac Delayed Rectifier Kv1.5 Channel” Biophys. J. 66:A205; abstract No. Tu-Pos383. |
Aps, C., F. Reynolds (1978) “An Intradermal Study of the Local Anaesthetic and Vascular Effects of the Isomers of Bupivacaine” J. Clin. Pharmac. 6:63-68. |
Burm, A.G.L. et al. (1994) “Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate” Br. J. Clin. Pharmac. 38:125-129. |
Reynolds, F. (1995) “In defence of bupivacaine” International Journal of Obstetric Anesthesia 4(2):93-108. |
Rutten, A. J. et al. (1993) “Tissue Distribution of Bupivacaine Enantiomers in Sheep” Chirality 5(7):485-491. |
Aberg, G. (1972) “Toxicological and Local Anaesthetic Effects of Optically Active Isomers of Two Local Anaesthetic Compounds” Acta Pharmacologica Et Toxicologica 31:273-286. |
Testa, B., W.F. Trager (1990) “Racemates Versus Enantiomers in Drug Development: Dogmatism or Pragmatism?” Chirality 2:129-133. |
Ariëns, E.J. (1991) “Racemic therapeutics—ethical and regulatory aspects” Eur. J. Clin. Pharmacol. 41(2):89-93. |
Rutten, A.J., L.E. Mather, C.F. McLean (1991) Cardiovascular Effects and Regional Clearances of I.V. Bupivacaine in Sheep: Enantiomeric Analysis. Br. J. Anaesthesia 67:247-256. |
Luduena, F.P., E.F. Bogado, B.F. Tullar (1972) “Optical Isomers of Mepivacaine and Bupivacaine” Arch. Int. Pharmacodyn 200(2):359-369. |
Rutten, A.J. et al. (1992) “Postoperative course of plasma protein binding of lignocaine, ropivacaine and bupivacaine in sheep” J. Pharm. Pharmacol. 44:355-358. |
Lee-Son, S. et al. (1992) “Stereoselective Inhibition of Neuronal Sodium Channels by Local Anesthetics” Anesthesiology 77(2):324-335. |
Wang, G.K. et al. (1992) “Altered Stereoselectivity of Cocaine and Bupivacaine Isomers in Normal and Batrachotoxin-modified Na+ channels” J. Gen. Physiol. 100(6):1003-1020. |
Luduena, F.P., B.F. Tullar (1970) “Optical isomers of an aminoacyl xylidide” Chemical Abstracts 73(5); abstract No. 25314a. |
Clark, B.J., A. Hamdi (1991) “Reversed-phase and chiral high-performance liquid chromatographic assay of bupivacaine and its enantiomers in clinical samples after continuous extraplural infusion” Journal of Chromatography 553:383-390. |
Ariëns, E.J. (1990) “Racemische therapeutica probleemmiddelen” Pharmaceutisch Weekblad 125(2):552-554. |
Ariëns, E.J. (1990) “Stereoselectivity in pharmacodynamics and pharmacokinetics” Schweiz. Med. Wochenschr 120(5):131-134. |
Gristwood, R. et al. (1994) “Reduced cardiotoxicity of levobupivacaine compared with racemic bupivacaine (Marcaine): new clinical evidence” Exp. Opin. Invest. Drugs 3(11):1209-1212. |
Albright, G.A. (1979) “Cardiac Arrest Following Regional Anesthesia with Etidocaine or Bupivacaine” Anesthesiology 51:285-287. |
Prentiss, J.E. (1979) “Cardiac Arrest Following Caudal Anesthesia” Anesthesiology 50(1):51-53. |
Moore, D.C. et al. (1976) “Arterial and Venous Plasma Levels of Bupivacaine Following Epidural and Intercoastal Nerve Blocks” Anesthesiology 45(1):39-45. |
Moore, D.C. et al. (1976) “Arterial and Venous Plasma Levels of Bupivacaine Following Peripheral Nerve Blocks” Anesthesia and Analgesia . . . Current Researches 55(6):763-768. |
Moore, D.C. et al. (1977) “Bupivacaine (Marcaine): An Evaluation of its Tissue and Systemic Toxicity in Humans” Acta Anesth. Scand. 21:109-121. |
Kuhnert, B.R. et al. (1981) “Bupivacaine disposition in mother, fetus and neonate” Federation Proceedings 40(31):684. |
Rowland, M., T.N. Tozer, eds. (1995) Clinical Pharmacokinetics Concepts and Applications; Williams & Wilkins; (Chapter 7):83-88. |
Mather, L.E. (1991) “Dispositon of Mepivacaine and Bupivacaine Enantiomers in Sheep” British Journal of Anaesthesia 67:239-246. |
DuPen, S.L. et al. (1992) “Chronic epidural bupivacaine—opioid infusion in intractable cancer pain” Pain 49:293-300. |
Honerjäger, P. (1986) “The contribution of Na channel block to the negative inotropic effect of antiarrhythmic drugs” Basic Res. Cardiol. 81(Suppl 1):33-37. |
Fozzard, H.A., J.A. Wasserstrom (1985) “Voltage Dependence of Intracellular Sodium and Control of Contraction” In Zipes D.P., E. Jalife (eds) Grune & Stratton, Orlando; 51-57. |
Schlepper, M. (1989) “Cardiodepressive effects of antiarrhythmic drugs” European Heart Journal 10(Suppl E):73-80. |
Reiz, S., S. Nath (1986) “Cardiotoxicity of Local Anaesthetic Agents ”Br. J. Anaesth. 58:736-746. |
DeJong, R. H., N. L. Davis (1981) “Treating Bupivacaine Arrhythmias” Reg. Anesth. 6:99-103. |
Strichartz, G.R. (1988) “Neutral physiology and local anesthetic action” In: Neural Blockage in Clinical Anesthesia and Management of Pain. Cousins, J.J., P.O. Bridenbaugh (eds), J.B. Lippincott Company, Philadelphia; 25-45. |